Other Event

Other Event

Other Adverse Events are non-serious adverse events that exceed a specific frequency threshold (typically 5% within any study arm). These events are reported to provide comprehensive safety information about all noteworthy adverse occurrences during clinical trials. Each other event is categorized by term, organ system, assessment type, and source vocabulary for standardized reporting.

Other Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Other Event

Study -> Results Section -> Adverse Events Module -> Other Event -> Other Event Stats

Other Event


Ignite Creation Date: 2025-12-24 @ 4:18 PM
Ignite Modification Date: 2025-12-25 @ 2:15 PM
NCT ID: NCT01722266
Term: Transient Nausea
Organ System: Gastrointestinal disorders
Assessment Type: SYSTEMATIC_ASSESSMENT
Source Vocabulary: None
Notes: Transient nausea reported at the time of initiation of liraglutide for first 2-5 days and then another 2-4 days at the time of escalation of the dose. Nausea is a common side effect of liralgutide.
Study: NCT01722266
Study Brief: Liraglutide in the Treatment of Type 1 Diabetes Mellitus
Other Event Stats (If Any):

Other Event Stats

Group ID # Events # Affected # At Risk View
EG000 3 3 17 View
EG001 9 9 15 View
EG002 10 10 13 View
EG003 11 11 18 View